Editorial: Epidemiology, diagnosis, prognosis and treatment of rare immune-mediated diseases of the central nervous system

Barbara M P Willekens; Ilka Kleffner; Beatrijs Wokke

doi:10.3389/fneur.2023.1342817

Editorial: Epidemiology, diagnosis, prognosis and treatment of rare immune-mediated diseases of the central nervous system

Front Neurol. 2023 Dec 13:14:1342817. doi: 10.3389/fneur.2023.1342817. eCollection 2023.

Authors

Barbara M P Willekens^{1

2

3}, Ilka Kleffner⁴, Beatrijs Wokke⁵

Affiliations

¹ Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.
² Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
³ Laboratory of Experimental Hematology, Faculty of Medicine and Health Sciences, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
⁴ Department of Neurology, University Hospital Knappschaftskrankenhaus, Ruhr University Bochum, Bochum, Germany.
⁵ Department of Neurology, Erasmus Medical Center, Rotterdam, Netherlands.

No abstract available

Keywords: GFAP; MOGAD; autoimmune encephalitis (AIE); neuromyelitis optica spectrum disorder (NMOSD); neurosarcoidosis; rare disease; systemic disorders.

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.